HUTCHMED (HCM) News Today → Executive Order To Wipe Out Your Bank Accounts (From Oasis Gold) (Ad) Free HCM Stock Alerts GBX 284.99 +1.99 (+0.70%) (As of 06:52 AM ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsHeadlinesStock AnalysisChartCompetitorsHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 15, 2024 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: HUTCHMED (HCM) and PAVmed (PAVM)May 8, 2024 | markets.businessinsider.comHUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board CommitteeApril 24, 2024 | finance.yahoo.comHUTCHMED (China) (LON:HCM) shareholders are up 8.2% this past week, but still in the red over the last five yearsApril 21, 2024 | morningstar.comHUTCHMED (China) Ltd ADRMarch 28, 2024 | lse.co.ukLONDON BRIEFING: JD Sports backs outlook; Spirent accepts new offerMarch 15, 2024 | finance.yahoo.comHCM Mar 2024 30.000 callFebruary 28, 2024 | markets.businessinsider.comHUTCHMED Hold Rating: Cautious Optimism Amidst Stable Outlook and International Growth PotentialFebruary 28, 2024 | finanznachrichten.deHUTCHMED (China) Limited: HUTCHMED Reports 2023 Full Year Results and Provides Business UpdatesFebruary 28, 2024 | msn.comHutchison China MediTech reports FY resultsFebruary 28, 2024 | markets.businessinsider.comHUTCHMED Reports 2023 Full Year Results and Provides Business UpdatesFebruary 28, 2024 | markets.businessinsider.comHUTCHMED Turns To Profit In FY23, Revenue Surges; Stock Up In Pre-marketFebruary 20, 2024 | au.finance.yahoo.comHUTCHMED (China) Ltd (H7T2.BE)February 20, 2024 | finance.yahoo.comHUTCHMED (China) Limited's (LON:HCM) biggest owners are private equity firms who got richer after stock soared 4.3% last weekFebruary 19, 2024 | msn.comWall Street Analysts See a 75.05% Upside in HUTCHMED (HCM): Can the Stock Really Move This High?February 7, 2024 | markets.businessinsider.comMaintaining Hold on HUTCHMED: Mixed FRUTIGA Results and Fair Valuation Limit UpsideFebruary 2, 2024 | markets.businessinsider.comHUTCHMED Announces that Inmagene Exercises Option to License Two Drug Candidates as Part of Strategic PartnershipFebruary 2, 2024 | finance.yahoo.comHUTCHMED Announces that Inmagene Exercises Option to License Two Drug Candidates as Part of Strategic PartnershipFebruary 1, 2024 | finance.yahoo.comHUTCHMED to Announce 2023 Final ResultsJanuary 30, 2024 | finanznachrichten.deHUTCHMED (China) Limited: HUTCHMED Receives ELUNATE (fruquintinib) Marketing Approval in Hong Kong for Treatment of Metastatic Colorectal CancerJanuary 30, 2024 | markets.businessinsider.comHUTCHMED Announces Marketing Approval For ELUNATE By Pharmacy And Poisons Board Of Hong KongJanuary 18, 2024 | msn.comAfter Plunging -10.7% in 4 Weeks, Here's Why the Trend Might Reverse for HUTCHMED (HCM)November 30, 2023 | finance.yahoo.comHUTCHMED Highlights Clinical Data to be Presented at 2023 ESMO Asia and ESMO Immuno-Oncology CongressesNovember 30, 2023 | finance.yahoo.comHUTCHMED Highlights Clinical Data to be Presented at 2023 ESMO Asia and ESMO Immuno-Oncology CongressesNovember 27, 2023 | msn.comHUTCHMED (China) Limited - ADR (HCM) Price Target Increased by 5.11% to 26.63November 25, 2023 | benzinga.comHUTCHMED (China) Stock (NASDAQ:HCM), Analyst Ratings, Price Targets, PredictionsNovember 24, 2023 | markets.businessinsider.comHUTCHMED’s Global Expansion and New Product Launches Bolster Buy Rating: An Analysis of Growth Prospects and Market PotentialNovember 10, 2023 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: HUTCHMED (HCM), Bayer (OtherBAYRY) and Compass Therapeutics (CMPX)November 6, 2023 | morningstar.comHUTCHMED (China) Ltd HCMOctober 16, 2023 | benzinga.comHUTCHMED Highlights Clinical Data to be Presented at ESMO Congress 2023October 16, 2023 | finance.yahoo.comHUTCHMED Highlights Clinical Data to be Presented at ESMO Congress 2023September 29, 2023 | stockhouse.comHUTCHMED Announces Submission of New Drug Application for Fruquintinib for Previously Treated Metastatic Colorectal Cancer in JapanSeptember 25, 2023 | finance.yahoo.comIs HUTCHMED (China) Ltd (HCM) Set to Underperform? Analyzing the Factors Limiting GrowthSeptember 13, 2023 | finance.yahoo.comPrivate equity firms account for 44% of HUTCHMED (China) Limited's (LON:HCM) ownership, while institutions account for 28%September 11, 2023 | benzinga.comHUTCHMED Completes Patient Enrollment of a Bridging Study of Tazemetostat in Patients with Relapsed/Refractory Follicular Lymphoma in ChinaSeptember 11, 2023 | finance.yahoo.comHUTCHMED Completes Patient Enrollment of a Bridging Study of Tazemetostat in Patients with Relapsed/Refractory Follicular Lymphoma in ChinaSeptember 11, 2023 | finance.yahoo.comDecoding HUTCHMED (China) Ltd (HCM)'s Performance Potential: A Deep Dive into Key MetricsAugust 29, 2023 | finanznachrichten.deHUTCHMED (China) Limited: HUTCHMED Receives Breakthrough Therapy Designation in China for Savolitinib for Gastric CancerAugust 28, 2023 | finance.yahoo.comHUTCHMED Receives Breakthrough Therapy Designation in China for Savolitinib for Gastric CancerAugust 22, 2023 | markets.businessinsider.comBank of America Securities Sticks to Its Buy Rating for HUTCHMED (HCM)August 21, 2023 | markets.businessinsider.comGoldman Sachs Remains a Hold on HUTCHMED (HCM)August 11, 2023 | msn.comHutchmed: Attractive Chinese R&D GiantAugust 3, 2023 | finance.yahoo.comHUTCHMED (China) First Half 2023 Earnings: EPS: US$0.20 (vs US$0.19 loss in 1H 2022)July 19, 2023 | finance.yahoo.comWall Street Analysts Think HUTCHMED (HCM) Could Surge 141.13%: Read This Before Placing a BetJuly 9, 2023 | finance.yahoo.comHUTCHMED Initiates Phase I Study of its novel SHP2 inhibitor HMPL-415 for Advanced Malignant Solid Tumors in ChinaJune 26, 2023 | finance.yahoo.comHUTCHMED to Announce 2023 Half-Year Financial ResultsJune 16, 2023 | finanznachrichten.deHUTCHMED (China) Limited: HUTCHMED and Takeda Announce Publication of Phase III FRESCO-2 Results in The LancetJune 1, 2023 | finance.yahoo.comHUTCHMED (China) (LON:HCM investor five-year losses grow to 53% as the stock sheds UK£125m this past weekMay 25, 2023 | finance.yahoo.comHUTCHMED Highlights Presentations at the 2023 ASCO Annual MeetingMay 25, 2023 | finance.yahoo.comTakeda and HUTCHMED Announce New Drug Application (NDA) for Fruquintinib for Treatment of Previously Treated Metastatic Colorectal Cancer Granted Priority ReviewMay 10, 2023 | benzinga.comHUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committees Get HUTCHMED News Delivered to You Automatically Sign up to receive the latest news and ratings for HCM and its competitors with MarketBeat's FREE daily newsletter. Email Address It's time to ween off Chinese lithium! (Ad)As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closely Learn how this American company is leading the lithium-ion revolution HCM Media Mentions By Week HCM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HCM News Sentiment▼0.000.76▲Average Medical News Sentiment HCM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HCM Articles This Week▼00▲HCM Articles Average Week Get HUTCHMED News Delivered to You Automatically Sign up to receive the latest news and ratings for HCM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: HIK News Today INDV News Today AGY News Today APH News Today ANCR News Today EAH News Today CEL News Today STX News Today CHLL News Today MXC News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:HCM) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredAlert: Your Bank is Dying – Act Now or Lose Everything!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put...Priority Gold | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | Sponsored